Charles Schwab’s Loxo Oncology, Inc LOXO Stock Holding History

Charles Schwab’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-207,124	Closed	-$29M	–	3225
2018 Q4	$29M	Buy	207,124 +346	+0.2%	+$52.5K	0.02%	743
2018 Q3	$35.3M	Buy	206,778 +77,762	+60%	+$13.1M	0.02%	733
2018 Q2	$22.4M	Buy	129,016 +18,041	+16%	+$2.71M	0.02%	997
2018 Q1	$12.8M	Buy	110,975 +2,960	+3%	+$315K	0.01%	1320
2017 Q4	$9.09M	Buy	108,015 +2,274	+2%	+$190K	0.01%	1540
2017 Q3	$9.74M	Buy	105,741 +24,025	+29%	+$1.87M	0.01%	1453
2017 Q2	$6.55M	Buy	81,716 +7,824	+11%	+$434K	0.01%	1648
2017 Q1	$3.11M	Buy	73,892 +30,533	+70%	+$1.26M	﹤0.01%	2007
2016 Q4	$1.39M	Buy	43,359 +2,310	+6%	+$59.2K	﹤0.01%	2318
2016 Q3	$1.07M	Buy	41,049 +20,449	+99%	+$535K	﹤0.01%	2393
2016 Q2	$478K	Buy	20,600 +7,400	+56%	+$184K	﹤0.01%	2601
2016 Q1	$361K	Hold	13,200	–	–	﹤0.01%	2713
2015 Q4	$376K	Buy	+13,200	New	+$354K	﹤0.01%	2770

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Charles Schwab's LOXO Position: Q1 2019 in Review

Charles Schwab sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 207,124 shares — an estimated $29M sold.

Charles Schwab first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $35.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Charles Schwab reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Charles Schwab sold 207,124 Loxo Oncology, Inc shares in Q1 2019, an estimated $29M.
Charles Schwab first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
Charles Schwab's Loxo Oncology, Inc position peaked at $35.3M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.